# APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/apl-2-a-complement-c3-inhibitor-may-potentially-reduce-both-intravascular-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Delphine El Mehdi,F Grossi,Pascal Deschatelets,Humphrey Pullon,Lisa Tan,Carolina Vega,Cedric Francois |
| Citations | 8 |
| DOI | 10.1016/j.molimm.2017.06.039 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2752712551 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Delphine El Mehdi](https://scholariq.org/researchers/delphine-el-mehdi/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.